TORIPALIMAB
Clinical trials for TORIPALIMAB explained in plain language.
Never miss a new study
Get alerted when new TORIPALIMAB trials appear
Sign up with your email to follow new studies for TORIPALIMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test aggressive new drug combo in fight against Fast-Moving lung cancer
Disease control Recruiting nowThis study is testing whether adding two newer drugs, toripalimab and surufatinib, to the standard treatment of chemotherapy and radiation can better control a fast-growing type of lung cancer. It will involve about 47 adults with limited-stage small cell lung cancer. The goal is…
Matched conditions: TORIPALIMAB
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for inoperable esophageal cancer patients in trial
Disease control Recruiting nowThis study is testing a new combination of drugs and radiation to control advanced esophageal cancer that cannot be removed by surgery. It will involve 69 adults who have not had prior cancer treatment. The goal is to see if adding a drug called surufatinib to standard chemo-immu…
Matched conditions: TORIPALIMAB
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC